PreciseDx

GRCHealthcare

Innovating oncology diagnostics through the power of AI. PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

2019
Founded
7y
Age
$32M
Total funding
Healthcare
Area

Funding timeline

Aug 2024
Series B - PreciseDx
$21M
Jan 2022
Series A - PreciseDx
$11M